These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein. Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769 [TBL] [Abstract][Full Text] [Related]
63. The role of defective complement control in hemolytic uremic syndrome. Zipfel PF; Misselwitz J; Licht C; Skerka C Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689 [TBL] [Abstract][Full Text] [Related]
64. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580 [TBL] [Abstract][Full Text] [Related]
65. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Saland JM; Shneider BL; Bromberg JS; Shi PA; Ward SC; Magid MS; Benchimol C; Seikaly MG; Emre SH; Bresin E; Remuzzi G Clin J Am Soc Nephrol; 2009 Jan; 4(1):201-6. PubMed ID: 19005013 [TBL] [Abstract][Full Text] [Related]
66. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192 [No Abstract] [Full Text] [Related]
67. [Hemolytic uremic syndrome]. Mele C; Noris M G Ital Nefrol; 2007; 24(1):23-33. PubMed ID: 17342690 [TBL] [Abstract][Full Text] [Related]
68. Successful living-related renal transplantation in a patient with factor H antibody-associated atypical hemolytic uremic syndrome. Hofer J; Giner T; Cortina G; Jungraithmayr T; Masalskiene J; Dobiliene D; Mitkiene R; Pundziene B; Rudaitis S Pediatr Transplant; 2015 Aug; 19(5):E121-5. PubMed ID: 26037622 [TBL] [Abstract][Full Text] [Related]
69. Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon? Kavanagh D; Pappworth IY; Anderson H; Hayes CM; Moore I; Hunze EM; Bennaceur K; Roversi P; Lea S; Strain L; Ward R; Plant N; Nailescu C; Goodship TH; Marchbank KJ Clin J Am Soc Nephrol; 2012 Mar; 7(3):417-26. PubMed ID: 22223611 [TBL] [Abstract][Full Text] [Related]
70. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Loirat C; Niaudet P Pediatr Nephrol; 2003 Nov; 18(11):1095-101. PubMed ID: 13680331 [TBL] [Abstract][Full Text] [Related]
78. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance. Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555 [TBL] [Abstract][Full Text] [Related]